E-LIB Suche - Ergebnisse für: Doğer, E

1

Characteristics of Turkish children with Type 2 diabetes at..:

Hatun, S. ; Yesiltepe Mutlu, G. ; Cinaz, P....
Diabetic Medicine. 36 (2019) 10 - p. 1243-1250 , 2019

Link: https://doi.org/10.1111/..

2

Prospective case control comparison of fetal intrapartum ox..:

Caliskan, E. ; Ozdamar, D. ; Doger, E....
International Journal of Obstetric Anesthesia. 19 (2010) 1 - p. 77-81 , 2010

Link: https://doi.org/10.1016/..

3

The use of albendazole sulphoxide as a scolicidal agent for..:

Doǧer, E ; Hökelek, M ; Doǧer, A
Parasitology International. 47 (1998) - p. 382 , 1998

Link: https://doi.org/10.1016/..

4

The analysis of TMS brain mapping of plastic changes in sca..:

Gok, K. ; Doger, E.N. ; Goztepe, M.B....
European Neuropsychopharmacology. 27 (2017) - p. S714 , 2017

Link: https://doi.org/10.1016/..

5

Neuropsychological consequences of childhood medulloblastom..:

Doger de Spéville, E. ; Kieffer, V. ; Dufour, C....
Neurochirurgie. 67 (2021) 1 - p. 90-98 , 2021

Link: https://doi.org/10.1016/..

6

Predicting future UK nighttime urban heat islands using obs..:

Doger de Speville, Charlotte R. E. ; Seviour, William J.M. ; Lo, Y. T. Eunice
Environmental Research Letters. , 2023

Link: https://doi.org/10.1088/..

7

Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cis..:

Tourneau, C. Le ; Takacsi-Nagy, Z. ; Finzi, L....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. S99 , 2023

Link: https://doi.org/10.1016/..

8

EP08.01-109 TACTI-002: A Phase II Study of Eftilagimod Alph..:

Forster, M. ; Krebs, M. ; Majem, M....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S395 , 2022

Link: https://doi.org/10.1016/..

9

A phase I dose expansion study of NBTXR3, radiation enhanci..:

Le Tourneau, C. ; Calugaru, V. ; Moreno, V....
Journal of Geriatric Oncology. 12 (2021) 8 - p. S9-S10 , 2021

Link: https://doi.org/10.1016/..

10

OC-0515 NBTXR3 activated by radiotherapy in cisplatin-ineli..:

Le Tourneau, C. ; Calugaru, V. ; Takacsi-Nagy, Z....
Radiotherapy and Oncology. 161 (2021) - p. S399 , 2021

Link: https://doi.org/10.1016/..

11

Phase I Study of Novel Radioenhancer NBTXR3 Activated by Ra..:

Le Tourneau, C. ; Calugaru, V. ; Takacsi-Nagy, Z....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e392 , 2021

Link: https://doi.org/10.1016/..

12

NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Acti..:

Le Tourneau, C. ; Calugaru, V. ; Borcoman, E....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e792 , 2020

Link: https://doi.org/10.1016/..

13

OC-0560: RT-activated hafnium oxide nanoparticles in cispla..:

Le Tourneau, C. ; Calugaru, V. ; Borcoman, E....
Radiotherapy and Oncology. 152 (2020) - p. S312 , 2020

Link: https://doi.org/10.1016/..

14

Phase I study of CC-90010, a reversible, oral BET inhibitor..:

Moreno, V. ; Sepulveda, J.M. ; Vieito, M....
Annals of Oncology. 31 (2020) 6 - p. 780-788 , 2020

Link: https://doi.org/10.1016/..

15

Hafnium oxide nanoparticles (NBTXR3) activated by radiother..:

Le Tourneau, C. ; Calugaru, V. ; Borcoman, E....
International Journal of Radiation Oncology*Biology*Physics. 106 (2020) 5 - p. 1142-1143 , 2020

Link: https://doi.org/10.1016/..